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Abstract
Background: Mucinous cystic neoplasms of the liver (hepatobiliary cystadenomas) are rare neoplastic
lesions. Such cysts are often incorrectly diagnosed and managed, and carry a risk of malignancy. The
objective of this study was to review the surgical experience with these lesions over 15 years.
Methods: A retrospective chart review identified consecutive patients undergoing surgery for liver
cystadenomas from 1997–2011. Clinical data were collected and summarized.
Results: Thirteen patients (mean age 51 years, 12/13 females) with cysts 4.6–18.1 cm were identified.
Most cysts were located in the left lobe/centrally (11/12) and had septations (8/13). Mural nodularity was
infrequent (3/13). Nine patients had liver resection/enucleation, whereas four had unroofing. Frozen
section analysis had a high false-negative rate (4/6). All patients had cystadenomas, of which two had foci
of invasive carcinoma (cystadenocarcinoma) within mural nodules. There was no 90-day mortality. All but
one patient (myocardial infarction) were alive at a median follow-up of 23.1 months. No patient with
unroofing has developed malignancy to date.
Conclusions: Non-invasive hepatobiliary cystadenomas present as large central/left-sided cysts in
young or middle-aged women. Associated malignancy was relatively uncommon and found within mural
nodules. Intra-operative frozen section analysis was ineffective at ruling out cystadenomas. Complete
excision is recommended, but close follow-up might be considered in patients with a prohibitive technical
or medical risk, in the absence of nodularity on high-quality imaging.
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Introduction
Liver cysts, once thought to be relatively rare,1 are now understood
to be common incidental findings on cross-sectional imaging.2
The differential diagnosis of such cysts is complex, and includes
primary hepatobiliary cysts (simple cyst, polycystic disease, muci-
nous cystic neoplasm, cystic intra-ductal biliary neoplasms and
intra-hepatic biliary cysts/Caroli’s disease), infectious collections
(pyogenic, parasitic and fungal) and other cysts (traumatic,
degenerative and post-ablation).3
Mucinous cystic neoplasms (MCN, hepatobiliary cystadeno-
mas), also commonly referred to by its subtype of mucinous cysta-
denoma, or neoplastic cyst of the liver, are rare lesions, with an
estimated incidence of 1 in 20 000–100 000 for non-invasive MCN
and 1 in 10 000 000 for cystadenocarcinoma.4 They can present
with non-specific abdominal complaints, can be found incidentally
on cross-sectional imaging or can be found on a pathological speci-
men after the unroofing or enucleation of presumed benign cysts.
Although the natural history of MCN is uncertain, many authors
have recommended complete excision of presumed or confirmed
lesions on the basis of potential malignant evolution to cystadeno-
carcinoma.5,6 While cases of associated malignancy have clearly
been documented in the literature,7,8 this risk remains poorly
defined, as the total body of published literature on this pathology
remains small. In this context, this study sought to review a single
tertiary-care centre’s experience in patients who underwent liver
surgery for MCN and associated cystadenocarcinomas of the liver.
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Patients and methods
After obtaining approval from the Ottawa Hospital Research
Ethics Board, the charts of eligible patients were obtained and
reviewed retrospectively (January 1997 to December 2011).
Patients were included in the study after undergoing surgery at
our institution for hepatic cysts, and had pathologically confirmed
hepatic MCN with or without an associated cystadenocarcinoma.
Patients who underwent surgery at outside institutions and were
only followed in our clinic were excluded. Patients who underwent
surgery for presumed MCN but had simple cysts on final pathol-
ogy were excluded, as were patients with cystic variants of biliary
intra-ductal papillary neoplasm (Bil-IPN). Eligible patients were
identified from surgeon records and hospital charts using proce-
dure codes, discharge diagnoses and pathological data. Independ-
ent review of selected pathological slides was carried out by the
study pathologist (C.M.), where doubt existed regarding the diag-
nosis of MCN.
Patients with hepatic cysts were referred to our institution for
surgical consultation after ultrasound imaging of the liver.
Patients with symptomatic cysts or with clinical or radiological
suspicion for MCN were further imaged with a dedicated liver
computed tomography (CT) scan and/or magnetic resonance
imaging (MRI). MRIs were systematically obtained when the
diagnosis of MCN on CT was inconclusive or to characterize a
suspicion of mural nodularity. Patients with a suspicion of MCN
underwent definitive surgery, in the form of a formal liver resec-
tion and/or complete enucleation. Patients who were found to
have MCN on pathology after unroofing of presumed simple liver
cysts were assessed by our group and offered definitive surgery, if
medically fit and if a resection was technically feasible. All opera-
tive frozen sections were done at the surgeon’s discretion. Patients
with an incomplete resection were followed clinically and radio-
logically every 6 months, or until the patient declined further
follow-up.
Pre-operative data (demographics, comorbidities, symptoms,
examination features, imaging findings and blood tests), operative
data (type of procedure, frozen section analysis, operative time
and blood transfusion) and post-operative data (length of stay,
pathology, complications and follow-up) were extracted from the
patients’ records. Post-operative complications were compiled
according to the Dindo–Clavien classification. Follow-up data
were obtained from clinic notes and phone records. All follow-up
imaging studies were reviewed.
Results
Thirteen patients underwent surgery for liver MCN between 1997
and 2011, of which 8 had surgery in 2008–2011. Demographical
detail and presenting findings are documented in Table 1. Ten of
13 patients were under 60 years of age. Almost all patients had
normal serum liver function tests. Serum carbohydrate antigen
19-9 (CA 19-9) levels were not routinely assessed.All patients who
underwent only ultrasound examination were treated prior to
1999. All but one cyst were located centrally or within the left liver
(Fig. 1).
Operative and post-operative characteristics are presented in
Table 2. All fully-excised central or right-sided cysts were treated
with enucleation (n = 6), whereas fully-excised left-sided cysts (n
= 3) underwent formal liver resection. Three patients underwent
unroofing as a direct consequence of false-negative frozen
sections. An operative complication occurred in one patient
who suffered an inferior vena cava (IVC) injury with immediate
reconstruction.
Immediate peri-operative complications occurred in six
patients. The Dindo–Clavien grading was: grade 4a (myocardial
Table 1 Patient characteristics (n = 13)
Patient demographics
Gender, female 12
Age, years, mean  SD 51.2  15.9, range 29–87
BMI, kg/m2, mean  SD 29.4  6.0
ASA I/II/III/IV 0/6/6/1
Presenting symptoms
Abdominal discomfort 11
Early satiety/nausea/vomiting 5
Weight loss 2
Asymptomatic 1
Physical exam findings
None 6
Epigastric fullness/mass 5
Abdominal tenderness 4
Definitive imaging studya
Ultrasound 2
MRI 7
CT 3
Imaging characteristics
Maximal cyst diameter 12.4  4.6 cm, range 4.8–18.1
Septations 8
Mural modules 3
Increasing in size 4
Reported as possible
cystadenomab
8
Reported as possible
cystadenocarcinomab
2
Cyst locationa
Left hemiliver only 5
Central 6
Right hemiliver only 1
aData are missing for one patient.
bInterpretation as reported by abdominal/liver radiologists at the authors'
institution.
ASA: American society of anesthesiologists score; BMI: body mass
index; CT: computed tomography; MRI: magnetic resonance imaging;
SD: standard deviation.
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infarction, n = 1), grade 3a (intra-abdominal haematoma, n = 1),
grade 2 (peri-operative blood transfusion, n = 5, ileus, n = 1,
pulmonary embolism, n = 1) and grade 1 (wound infection, n =
1). In addition, two patients developed delayed complications:
grade 3b (incisional hernia, n = 2) and grade 3a (chronic IVC
narrowing with temporary lower extremities venous stasis ulcera-
tion, n = 1). There was no 90-day mortality.
Final pathology revealed non-invasiveMCN in 11 patients. Two
patients had foci of invasion within mural nodules with negative
surgical margins (cystadenocarcinoma).
Among the four patients who underwent unroofing, three were
incorrectly presumed to have simple cysts. Two have declined
further surgery and are followed closely. The third patient, an
87-year-old male, was unfit for definitive surgery and died 13
months later of a second myocardial infarction (grade 4a compli-
cation during initial surgery). The fourth, a 44-year-old female,
had a massive central cyst compressing the three hepatic veins and
was highly symptomatic. She was not considered resectable from a
technical standpoint and underwent wide unroofing understand-
ing that recurrence was certain. After 40 months of close
follow-up with clear symptoms recurrence, the patient was
referred to another high-volume hepatobiliary centre for an
attempt at resection. During surgery, a definitive resection was not
deemed feasible, and the treating team carried out an internal
drainage procedure using a Roux loop. The patient remains well at
2 months of follow-up.
The median study follow-up was 23.1 months. All but four
patients were followed for at least 12 months. All but one patient
in the study were alive at maximal follow-up. No patient who
underwent enucleation or resection has had a recurrence. None of
the two patients with foci of cystadenocarcinoma have had local
recurrence or metastatic disease. No adjuvant therapy was given.
No malignant degeneration was identified among the four
patients who underwent unroofing (follow-up 6.8–62.9 months).
Discussion
The present study has addressed the management of intra-
hepatic MCN. This series adds to a relatively small body of lit-
erature pertaining to this rare pathology. Review of the literature
to 1990 would suggest that fewer than 300 cases have been
reported.5,6,9–16 Lesions identified in this study were described as
MCN (hepatobiliary cystadenomas) according to the most recent
WHO classification.17 These were composed of multiple cysts of
varying sizes, with no communication with the bile ducts. Using
microscopy, they demonstrated a well-defined capsule, a single-
layered simple cuboidal, columnar, or flat epithelium, and a base-
(a)
(b)
Figure 1 (a) T2-weighted magnetic resonance imaging (MRI) dem-
onstrating a 14 ¥ 15 cm centrally-located liver cystadenoma with
mural nodularity and inferior vena cava compression in a 63-year-old
female. (b) Computed tomography (CT) scan demonstrating an 11 ¥
8 cm centrally-located multi-sepatated liver cystadenoma arising
above the portal bifurcation in a 56-year-old female
Table 2 Procedures and outcomes (n = 13)
Item
Operative procedure
Liver resection 3
Enucleation/pericystectomy 6
Unroofinga 4
Intra-operative frozen section analysis 6
False-negative 4
Operative time, median, minutes 182, range 86–493
Hospital stay, median, days 6, range 4–19
Follow-up, median, months 23.1, range 0.3–159
Recurrence after resection/enucleation 0/9
Cystadenocarcinoma recurrence 0/2
Progression to cystadenocarcinoma after
unroofing
0/4
aOne patient had both a left lateral liver sectionectomy and unroofing of
the medial cyst wall (included under unroofing).
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ment membrane (Fig. 2a). Mucin-containing vacuoles (intestinal
metaplasia) were typically seen. Underneath the basement mem-
brane, a layer of highly-cellular mesenchymal tissue was usually
present, resembling normal ovarian stroma.18 The ovarian-like
stroma was composed of bland spindle cells (Fig. 2b), which
typically stains with vimentin, actin, desmin, oestrogen, proges-
terone and inhibin.18 In general, MCN are nearly always muci-
nous, but a serous variety lacking an ovarian-like stroma is
recognized. Foci of epithelial dysplasia can occur in the epithelial
lining of MCN, from which mural nodules and ductal adenocar-
cinomas can arise, as was identified in this study. As the areas of
invasion are typically focal in nature, extensive sampling of these
neoplasms was required.
The present study only examined MCN and excluded the
recently-described cystic variant of Bil-IPN.15,18 Zen et al. have
argued that many older series of MCN may have been contami-
nated by cystic Bil-IPN, thus warranting careful clinical interpre-
tation of existing series, as had been the case with pancreatic
cystic lesions.15 Indeed, cystic Bil-IPN can be associated with
clinically-significant cyst formation, as a result of ductal dilation
and mucin plugging. It can be differentiated from MCN by the
presence of communication with the biliary tract on imaging or
pathology, and the absence of ovarian-type stroma on histology.
Unfortunately, ovarian-type stroma can sometimes be discon-
tinuous and require considerable sampling for identification.18
This distinction is further complicated by a rare variant of
MCN without ovarian-type stroma, which is sometimes seen in
men.18
This study has demonstrated that MCN present typically as
large cysts almost exclusively in young or middle-aged female
patients. This finding is consistent with existing series in the lit-
erature where almost all patients were females with an average age
in the late forties. Interestingly, Sang et al. identified 11 male
patients with such neoplastic cysts, although 9 of those in fact had
cystadenocarcinomas.16 While certain authors have suggested that
MCN can only be found in women,15 this study and other series in
the literature would suggest that males can account for 0–10.5% of
patients with this pathology when cystadenocarcinomas are
excluded.5,6,9,10,13–16 Similarly, the maximal mean cyst diameter was
found to be 12.4 cm in this study, which is comparable to other
series where cysts always averaged greater than 10 cm.5,6,9,10,13,14,16
The generally large volume of these neoplastic cysts is probably
related to the relative lack of symptoms associated with smaller
cyst sizes.
This study has demonstrated that the vast majority of cysts
(11/12) were located within the anatomical left lobe of the liver or
centrally in close proximity to the portal or hepatic veins conflu-
ences. Vogt et al. have reported a similar pattern whereby only
3/22 patients had a right lobe cyst, whereas the others had left-
sided (n = 14), central (n = 2) or caudate disease (n = 1).6 Wang
et al. reported similarly striking data of only 4/30 right lobe cysts.16
The underlying mechanism for this observation is not readily
apparent, but may reflect patterns of location of ectopic embry-
onic tissue normally found in the adult gallbladder.19
Intra-operative frozen section analysis was not effective at
ruling out MCN in this series, with 4/6 false-negative results. This
is an important finding in that simple liver cysts could not be
reliably differentiated from MCN in the operating room and this
in spite of pathological assessment. The reasons behind this
finding may pertain to insufficient or non-representative surgical
material, insufficient pathological sampling or difficult histologi-
cal interpretation. At least one other group has reported false-
negative results in the context of liver cysts.6 In light of poor
results from frozen section analysis, the present study would
suggest operative decisions for undifferentiated cysts should be
made on pre-operative imaging such as MRI or a triphasic CT
scan. Although not examined in this study, other groups have
advocated pre-operative cyst fluid analysis for CA 19-9 and carci-
noembryonic antigen, with mixed results.11,13
In this series, malignant cystadenocarcinoma was identified in
2/13 pathological specimens (15%). Both patients presented with
small foci of malignant cells within mural nodules that were iden-
tified pre-operatively. A third patient had an area of low-grade
dysplasia within her cyst, while a fourth had an area of nodularity
that did not contain carcinoma or dysplasia. While suggestive of
(a)
(b)
Figure 2 (a) Mucinous cystadenoma (10¥, haematoxylin and eosin
stain). There is a large cyst lined by a simple biliary-type columnar
epithelium. (b) The ovarian-like mesenchymal stroma is seen under-
neath the simple epithelium (100¥, haematoxylin and eosin stain).
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the potential for malignant transformation, these data do not
allow for a more accurate understanding of the natural history of
MCN, as such information would have to be derived from a likely
prolonged period of non-operative observation. The rate of
malignancy within comparable surgical or pathological series of
MCN was highly variable at 3.4–42%.5,6,9,10,12,14,16,20 These data are
unfortunately difficult to interpret, as many series examined both
de novo cystadenocarcinomas as well as malignant degeneration
within existing MCN.6 De novo lesions have been reported more
frequently in men, and may harbour a different prognosis.6,9,14
This issue is further confused by data on cystic variants of intra-
ductal papillary neoplasms of the bile ducts, which appear to
harbour a higher risk of malignancy. Li et al. have indeed reported
a malignancy rate of 38.5% with MCN and of 78.9% with
B-IPN.20 In contrast, Zen et al. reported rates of 3% and 100%,
respectively.15 It is likely that this pathological entity may have
contaminated certain series of MCN, and thus overestimated the
risk of malignancy.
Given the association with malignancy, many have advocated
complete excision of all intra-hepatic MCN.5,6 That being said, the
natural history of this lesion is not well understood, and malig-
nant degeneration is likely to occur over several years.7,8 In the
present study, four patients underwent incomplete excision, with
no evidence of progression to malignancy after follow-up times of
6.8–62.9 months. Two patients have had follow-up times of at
least 3 and 5 years, respectively. In this context, the authors’ man-
agement strategy has been to offer definitive surgery to all patients
with sufficient clinical or radiological suspicion of MCN, with the
exception of patients who are unfit for major liver surgery or those
who are deemed technically unresectable. Older patients or mar-
ginal surgical candidates without evidence of mural nodularity
could be considered for surgery or close follow-up on a case-by-
case basis after consensus discussion. In the case of technical unre-
sectability, a second opinion would be sought at another
hepatobiliary centre.
The current study has clear limitations. Most significantly, it
has a small sample size, which limits one’s ability to draw broad
conclusions. That being said, when compared against the existing
literature on this topic, the current series is in fact one of only a
handful of publications with at least 10 patients originating from
a Western centre.5,6,9–11 In addition to the above concern, this
work is limited by its retrospective nature, in that study variables
were limited to available reports and pathological specimens.
Although this limitation is unavoidable in retrospective series,
our group has attempted to mitigate this potential source of bias
by seeking additional sources of information, such as surgeon
and phone records, and by reviewing selected pathological speci-
mens. Finally, three patients were lost to follow-up after their first
post-operative visit owing to a long-distance travel time. Given
that all three patients had completely excised cysts it is unlikely,
although not impossible, that they would have experienced
recurrence without being referred back to our centre by their
primary care physicians.
Conclusion
In the current series, non-invasive MCN (hepatobiliary cystad-
enomas) of the liver presented as large central/left-sided cysts in
young or middle-aged women. Associated malignancy was rela-
tively uncommon and found within mural nodules. Intra-
operative frozen section analysis was ineffective at ruling out
MCN. Complete excision is recommended, but close follow-up
might be considered in patients with prohibitive technical or
medical risk, in the absence of nodularity on high-quality
imaging.
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